These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7840694)

  • 1. Rationale for metabolic support with amino acids and glucose-insulin-potassium (GIK) in cardiac surgery.
    Svedjeholm R; Håkanson E; Vanhanen I
    Ann Thorac Surg; 1995 Feb; 59(2 Suppl):S15-22. PubMed ID: 7840694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucose and insulin influences on heart and brain in cardiac surgery.
    Quinn DW; Pagano D; Bonser RS
    Semin Cardiothorac Vasc Anesth; 2005 Jun; 9(2):173-8. PubMed ID: 15920645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic intervention for the ischemic and post-ischemic heart.
    Svedjeholm R; Håkanson E; Szabó Z
    Wien Klin Wochenschr; 1999 Jul; 111(13):501-11. PubMed ID: 10444803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Metabolic support of the ischemic heart during cardiac surgery].
    Luna Ortiz P; Serrano Valdés X; Rojas Pérez E; de Micheli A
    Arch Cardiol Mex; 2006; 76 Suppl 4():S121-36. PubMed ID: 17469340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutamate and high-dose glucose-insulin-potassium (GIK) in the treatment of severe cardiac failure after cardiac operations.
    Svedjeholm R; Huljebrant I; Håkanson E; Vanhanen I
    Ann Thorac Surg; 1995 Feb; 59(2 Suppl):S23-30. PubMed ID: 7840695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin therapy as an adjunct to reperfusion after acute coronary ischemia: a proposed direct myocardial cell survival effect independent of metabolic modulation.
    Sack MN; Yellon DM
    J Am Coll Cardiol; 2003 Apr; 41(8):1404-7. PubMed ID: 12706939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced preservation of acutely ischemic myocardium using glucose-insulin-potassium solutions.
    Lazar HL
    J Card Surg; 1994 May; 9(3 Suppl):474-8. PubMed ID: 8069039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Glucose-insulin-potassium (GIK) in the reduction of acute myocardial ischemia after an aortocoronary bypass intervention].
    Dainese L; Polvani GL; Fumero A; Spirito R; Alamanni F; Agrifoglio M; Parolari A; Biglioli P
    G Ital Cardiol; 1999 May; 29(5):575-9; discussion 580-2. PubMed ID: 10367228
    [No Abstract]   [Full Text] [Related]  

  • 9. Enhanced preservation of acutely ischemic myocardium and improved clinical outcomes using glucose-insulin-potassium (GIK) solutions.
    Lazar HL
    Am J Cardiol; 1997 Aug; 80(3A):90A-93A. PubMed ID: 9293960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Glucose-insulin-potassium (GIK) in prevention and therapy of myocardial ischemia].
    Haider W; Hiesmayr M
    Wien Klin Wochenschr; 2000 Apr; 112(7):310-21. PubMed ID: 10849955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Changes in cardiac metabolism and their possible therapeutic use. (part II)].
    Carbó R; Guarner V
    Arch Cardiol Mex; 2004; 74(1):68-79. PubMed ID: 15125269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy with insulin in cardiac surgery: controversies and possible solutions.
    Doenst T; Bothe W; Beyersdorf F
    Ann Thorac Surg; 2003 Feb; 75(2):S721-8. PubMed ID: 12607718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of metabolically active drugs in the management of ischemic heart disease.
    Schofield RS; Hill JA
    Am J Cardiovasc Drugs; 2001; 1(1):23-35. PubMed ID: 14728049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucose-insulin-potassium therapy in adult patients undergoing cardiac surgery: a meta-analysis.
    Fan Y; Zhang AM; Xiao YB; Weng YG; Hetzer R
    Eur J Cardiothorac Surg; 2011 Jul; 40(1):192-9. PubMed ID: 21075642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic support for the postischaemic heart.
    Lancet; 1995 Jun; 345(8964):1552-5. PubMed ID: 7791443
    [No Abstract]   [Full Text] [Related]  

  • 16. Myocardial protection of insulin and potassium in a porcine ischemia-reperfusion model.
    Oates A; Nubani R; Smiley J; Kistler L; Hughey S; Theiss P; Perez-Tamayo RA; Eiferman D; Lonchyna V; Higgins RS
    Surgery; 2009 Jul; 146(1):23-30. PubMed ID: 19541007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic modulation of myocardial ischemia.
    Jani S; Bergmann SR
    Curr Cardiol Rep; 2006 Mar; 8(2):123-30. PubMed ID: 16524539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac metabolism in ischemic heart disease.
    Opie LH
    Arch Mal Coeur Vaiss; 1999 Dec; 92(12):1755-60. PubMed ID: 10665328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Attenuation of irreversible rat heart injury by reperfusion with metabolic protectors].
    Pisarenko OI; Serebriakova LI; Tsikitishvili OV; Studneva IM
    Biomed Khim; 2008; 54(6):659-70. PubMed ID: 19205425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of high-dose glucose-insulin-potassium on myocardial metabolism after coronary surgery in patients with Type II diabetes.
    Szabó Z; Arnqvist H; Håkanson E; Jorfeldt L; Svedjeholm R
    Clin Sci (Lond); 2001 Jul; 101(1):37-43. PubMed ID: 11410112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.